Sensitivity of FCV to recombinant feline interferon (rFeIFN)

Veterinary Research Communications

Volumn 32, Issue 2, 2008, Pages 167-174

  Ohe, Kyoko ^a   Takahashi, Toshikazu ^b   Hara, Daisuke ^b   Hara, Motonobu ^b  

^a University of Florida   (United States)

^b AZABU UNIVERSITY   (Japan)

Author keywords

FCV; RFeIFN; VBS

Indexed keywords

AMINO ACID; INTERCAT; RECOMBINANT INTERFERON; UNCLASSIFIED DRUG; VIRUS VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CALICIVIRUS; CAT DISEASE; DRUG SENSITIVITY; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; VESIVIRUS; VIRUS ISOLATION; VIRUS STRAIN;

CALICIVIRUS, FELINE; DRUG RESISTANCE, VIRAL; INTERFERONS; PHYLOGENY; VARIATION (GENETICS);

FELIDAE; FELINE CALICIVIRUS;

EID: 38349154956     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-007-9019-5     Document Type: Article

References (20)

1. Fulton, R. W. and Bunge, L. J. 1985. Susceptibility of feline herpesvirus 1 and 2 and feline calicivirus to feline interferon and recombinant human leukocyte interferons. Antimicrob. Agents, Chemother. 28: 688-699.
2. Gaskell, R. M. and Dawson, S. 1998. Feline respiratory disease. In: C.E. Greene (ed.), Infections Diseases of the Dog and Cat, 2nd edn, (WB Saunders, Philadelphia): 97-106.
3. Isaacs, A. and Lindenmann, J. 1987. Virus interference. I. The interferon. By A. Isaacs and J. Lindenmann, 1957. J. Interferon. Res. 7: 429-438.
4. Lindenmann, J. and Gifford, G. E. 1963. Studies on vaccinia virus plaque formation and its inhibition by interferon. III. A simplified plaque inhibition assay of interferon. Virology. 19: 302-309.
5. Mochizuki, M., Nakatani, H., Yoshida, M. 1994. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet. Microbiol. 39: 145-152.
6. Mochizuki, M., Kawakami, K., Hashimoto, M., Ishida, T. 2000. Recent epidemiological status of feline upper respiratory infections in Japan. J. Vet. Med. Sci. 62: 801-803.
7. Nagano, Y. and Kojima, Y. 1954. Pouvoir immuninant da virus vaccinal inactive par des rayons ultaviolets. C.R. Soci. Biol. 1700-1708.
8. Ninomiya, H., Fukutome, A., Kashima, M., Kobayashi, K., Shin, Y., Uchino, T., Motoyoshi, S. 1991. Effects of recombinant feline interferon on feline calicivirus infection. Proceeding of the12th annual meeting of Japanese society of clinical veterinary medicine. 384-387. (In Japanese)
9. Ohe K., Sakai S., Takahashi T., Sunaga F., Murakami M., Kiuchi A., Fukuyama M., Furuhata K., Hara M., Ishikawa Y., Taneno A. 2007 Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan, Vet.Res.Commun. 31: 497-507
10. Orito, E., Mizokami, M., Mizoguchi, N., Ohba, K., Tohnai, M., Yamanaka, H., Oguri, T., Hirashima, N., Koide, T., Kano, H. 1994. Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy. J. Hepatol. 21: 130-132.
11. Pedersen, N. C. 1993. Feline infectious diseases. (American Veterinary Publications, California, USA): 58-64.
12. Sato, Y., Ohe, K., Fukuyama, M., Furuhata, K., Kishikawa, S., Suzuki, Y., Kiuchi, A., Hara, M., Ishikawa, Y., Taneno, A. 2002a. Phylogenetic analysis of feline calicivirus capsid gene in infected cats. Jpn. J. Electroph. 46: 7-14.
13. Sato, Y., Ohe, K., Murakami, M., Fukuyama, M., Furuhata, K., Kishikawa, S., Suzuki, Y., Kiuchi, A., Hara, M., Ishikawa, Y., Taneno, A. 2002b. Phylogenetic analysis of field isolates of feline calicivirus (FCV) in Japan by sequencing part of its capsid gene. Vet. Res. Commun. 26: 205-219.
14. Uchino, T., Kouzuki, S., Yamane, Y., Motoyashi, S. 1991. Clinical effect of recombinant feline interferon (rFeIFN) on feline calicivirus infection (FCI). Proceeding of the12th annual meeting of Japanese society of clinical veterinary medicine. 388-395. (In Japanese)
15. Uchino, T., Kouzuki, S., Tsuruno, M., Yamane, Y., Uno, T., Kumai, H., Kobayashi, K., Kobayashi, K., Skurai, F., Sasaki, T., Shimoda, K., Shimoda, T., Kawamura, H., Tajima, T., Mochizuki, M., Motoyashi, S. 1992. Investigations of feline interferon and its therapeutic effects for field use (Report 1) Its therapeutic effects on FCI (feline calicivirus infection), Japanese Journal of Small Animal Practice. 11: 11-25. (In Japanese)
16. Uchino, T., Yamane, Y., Motoyashi, S. 1998. Research of 245 cases of field trial on clinical effect of recombinant feline interferon-ω (omega) on feline calicivirus infection (FCI). Proceedings of the 19th annual meeting of Japanese society of clinical veterinary medicine. 3: 58-76. (In Japanese)
17. Ueda, Y., Sakurai, T., Kasama, K., Satoh, Y., Atsumi, K., Hanawa, S., Uchino, T., Yanai, A. 1993. Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2′, 5′-oligoadenylate synthetase activity in the cat. J. Vet. Med. Sci. 55: 1-6.
18. Wagner, R. R. 1961. Biological studies of interferon. I. Suppression of cellular infection with eastern equine encephalomyelitis virus. Virology. 13: 323-337.
19. Yamamoto, K. J., Okuda, T., Yanai, K. 1990. Feline interferon no kenkyuu. II. Feline interferon no FHV hassyouyokuseikouka. Proceeding of 109th The Japanese Society of Veterinary Science. 153.
20. Yanai, K., Nakamura, N., Sudou, T. 1990. Feline interferon no kenkyuu. I. Feline interferon cDNA no cloning. Proceeding of 109th The Japanese Society of Veterinary Science. 153.